![Carlos E. Ibañez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carlos E. Ibañez
Keine laufenden Positionen mehr
Profil
Carlos E.
Ibañez was the founder of Abintus Bio, Inc. and served as Senior Vice President-CMC since 2020.
Former positions include Principal at Chiron Corp., Principal at Collateral Therapeutics, Inc., Principal at Activate Immunotherapy, Vice President-Product Development & Manufacturing at Tocagen, Inc., Principal at Chiron Viagene, Inc., and Member at Research Institute of Public Health.
Education includes a doctorate from the University of California San Diego.
Ehemalige bekannte Positionen von Carlos E. Ibañez
| Unternehmen | Position | Ende |
|---|---|---|
Abintus Bio, Inc.
 Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage gene therapy company | Gründer | 01.01.2025 |
Research Institute of Public Health | Corporate Officer/Principal | - |
Activate Immunotherapy
 Activate Immunotherapy BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Corporate Officer/Principal | - |
Collateral Therapeutics, Inc.
 Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Corporate Officer/Principal | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | - |
Ausbildung von Carlos E. Ibañez
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Collateral Therapeutics, Inc.
Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Commercial Services |
Activate Immunotherapy
Activate Immunotherapy BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Develops biopharmaceutical drugs | Health Technology |
Chiron Viagene, Inc.
 Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Commercial biotechnical research | Commercial Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Institute of Public Health | |
Abintus Bio, Inc.
Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage gene therapy company | Commercial Services |
